Cwm, LLC Palatin Technologies Inc Transaction History

Cwm, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Sep 15, 2021	BUY	$0.47 - $0.64 $1,880 - $2,560	4,000 New	4,000 $2,000
Q3 2020 Oct 19, 2020	SELL	$0.47 - $0.64 $1,880 - $2,560	-4,000 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$0.41 - $0.73 $1,640 - $2,920	4,000 New	4,000 $2,000
Q2 2020 Jul 22, 2020	SELL	$0.41 - $0.73 $1,640 - $2,920	-4,000 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$0.36 - $0.79 $1,440 - $3,160	4,000 New	4,000 $2,000
Q1 2020 Apr 28, 2020	SELL	$0.36 - $0.79 $1,440 - $3,160	-4,000 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$0.75 - $0.89 $3,000 - $3,560	4,000 New	4,000 $2,000
Q4 2019 Jan 27, 2020	SELL	$0.75 - $0.89 $3,000 - $3,560	-4,000 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$0.78 - $1.09 $3,120 - $4,360	4,000 New	4,000 $2,000
Q3 2019 Oct 22, 2019	SELL	$0.78 - $1.09 $3,120 - $4,360	-4,000 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$0.98 - $1.64 $3,920 - $6,560	4,000 New	4,000 $2,000
Q2 2019 Jul 31, 2019	SELL	$0.98 - $1.64 $3,920 - $6,560	-4,000 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$0.67 - $1.01 $2,680 - $4,040	4,000 New	4,000 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.